Prognostic value of metabolic syndrome in renal structural changes in type 2 diabetes.
Lijun ZhaoYutong ZouLin BaiLi ZhouHonghong RenYucheng WuYiting WangShuangqing LiQiaoli SuLinqiao TangYuancheng ZhaoHuan XuLin LiZhonglin ChaiMark E CooperNanwei TongJie ZhangFang LiuPublished in: International urology and nephrology (2022)
MetS is an independent prognostic predictor of ESKD in patients with T2D and DN, while adding the IFTA scores increased the prognostic value of MetS for renal outcome.